Invivyd, Inc. Common Stock IVVD
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T02:45:59.035Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:27:44.701517881Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-12T02:40:48.451703+00:00
Invivyd, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 6.32 | 458.7% | 958.0% | |||
| 25Δ | 5.71 | 482.0% | 859.4% | |||
| 30Δ | ||||||
| 35Δ | 0.94 | 194.9% | 67.1% | |||
| 40Δ | 0.88 | 201.5% | 61.1% | |||
| 45Δ | 0.82 | 208.1% | 55.0% | |||
| 50Δ | 0.77 | 214.6% | 49.0% | |||
| 55Δ | 0.71 | 221.2% | 42.9% | |||
| 60Δ | 0.65 | 227.8% | 36.9% | 1.05 | 258.4% | 15.5% |
| 65Δ | 0.60 | 234.4% | 30.8% | 1.12 | 244.7% | 13.1% |
| 70Δ | 0.54 | 241.0% | 24.7% | 1.19 | 231.1% | 10.8% |
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- 6.32
- IV
- 458.7%
- B/E move
- 958.0%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 5.71
- IV
- 482.0%
- B/E move
- 859.4%
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 0.94
- IV
- 194.9%
- B/E move
- 67.1%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 0.88
- IV
- 201.5%
- B/E move
- 61.1%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 0.82
- IV
- 208.1%
- B/E move
- 55.0%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 0.77
- IV
- 214.6%
- B/E move
- 49.0%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 0.71
- IV
- 221.2%
- B/E move
- 42.9%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 0.65
- IV
- 227.8%
- B/E move
- 36.9%
- Pseudo strike
- 1.05
- IV
- 258.4%
- B/E move
- 15.5%
65Δ
- Pseudo strike
- 0.60
- IV
- 234.4%
- B/E move
- 30.8%
- Pseudo strike
- 1.12
- IV
- 244.7%
- B/E move
- 13.1%
70Δ
- Pseudo strike
- 0.54
- IV
- 241.0%
- B/E move
- 24.7%
- Pseudo strike
- 1.19
- IV
- 231.1%
- B/E move
- 10.8%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 238.48% | |
| 215.55% | |
| 209.31% | |
| 276.06% | |
| 275.81% | |
| 361.40% |
Biotechnology
JANX
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology to treat cancer…
More →JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and…
More →JBIO
Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company is…
More →JSPR
Jasper Therapeutics Inc (JSPR) is a pioneering biopharmaceutical company dedicated to advancing hematopoietic stem cell therapies aimed at improving treatment outcomes for…
More →KARD
Kardigan, Inc. is an innovative technology company specializing in advanced software solutions for retail and e-commerce industries. With a strong focus on enhancing customer…
More →KLRA
Kailera Therapeutics, Inc. is a cutting-edge biotechnology company dedicated to developing innovative gene therapies for rare genetic diseases, addressing critical unmet medical…
More →